Company intelligence / Profile preview

TELA Bio

Malvern, Pennsylvania, United Statestelabio.gcs-web.com ↗

Ownership: Public · TELA
Development stage: Commercial

Overview

TELA Bio has commercialized a portfolio of reinforced biologic tissue matrices for soft-tissue reconstruction. Its flagship products—OviTex and OviTex PRS—are used in hernia repairs and plastic/reconstructive surgeries. The company reported $69.3 million in revenue for full year 2024 with strong growth in unit sales volume of its core products. In mid-April 2024, it launched OviTex IHR specifically for laparoscopic/robotic-assisted inguinal hernia repair, selling over 1,200 units by year-end. The company also markets Liquifix surgical glue from Advanced Medical Solutions Ltd.

Therapeutic areas: OtherGastroenterology
Modalities: DeviceBiologicPolymer-based device
Industry: Surgical Medical Devices

Drug pipeline

2 assets

OviTex

Commercial

Indications: Hernia repair, Abdominal wall reconstruction

1 more asset in the full pipeline.

Request access →

Partnerships

Advanced Medical Solutions Ltd. (distribution partnership for Liquifix surgical glue in the US)

Financials

Market cap: $37.1M
Total revenue: $19.3M
Enterprise value: $63.3M

Beyond the preview

Go deeper on TELA Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TELA Bio.

Explore the full profile